ALPHA BIORESEARCH SL -  

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 5.999.999 949.148 1
2015 0 5.913.080 806.155 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
UNIVERSITY COLLEGE LONDON2
YAQRIT LIMITED2
A2F ASSOCIATES LIMITED1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CONCENTRIS RESEARCH MANAGEMENT1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CROWDHELIX LIMITED1
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER1
EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE1
EUROPEAN LIVER PATIENTS ASSOCIATION1
FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
HEPYX LIMITED1
INTERNATIONAL MARKET ACCESS CONSULTING1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
MAST CARBON INTERNATION1
SERVICIO MADRILENO DE SALUD1
UNIVERSITA DEGLI STUDI DI PADOVA1
UNIVERSITAET BERN1
UNIVERSITAET LEIPZIG1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF BRIGHTON1

Constancy:

Total number of partners: 26
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 26
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-03-01NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242 A-TANGOparticipant5.999.99914
2015-05-01Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. CARBALIVEparticipant5.913.08014